Additionally, the affinity with which HLAs bind to their respective neoantigens has been a subject of interest in cancer immunogenomics, and an area that is expanding in silico immunogenomic tools, such as neoantigen prediction software which are being used to predict both HLA binding affinities for each tumor-specific antigen (179, 187). The gene discussed is HLA-S; the disease is neoplasm.